Prot#GED-0301-CD-003:A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy and Safety of mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects with Active Crohn’s Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date12/13/17 → 12/13/18

Funding

  • Quintiles, Inc. (GED-0301-CD-003 // GED-0301-CD-003)
  • Celgene Corporation (GED-0301-CD-003 // GED-0301-CD-003)